At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 6 enrolled
Drug / intervention
Fresh Frozen Plasmabiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy
In Brief
A Phase 1 clinical trial evaluating Fresh Frozen Plasma for Progressive Supranuclear Palsy. Completed, enrolled 6 participants across 1 site.
Detailed Summary
This is a phase 1, multi-center, open-label study of the safety, tolerability, pharmacodynamics, and preliminary efficacy of young (\<30 years of age) healthy male donor plasma transfusions in patients with PSP. Up to 10 subjects will receive once monthly 4-unit transfusions of young healthy male donor plasma for 6 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProgressive Supranuclear Palsy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedJun 2015
Primary CompletionDec 2017
Study CompletionDec 2019
TodayJul 2026
First PostedJun 2, 2015
Enrollment StartMay 1, 2015
Primary CompletionDec 1, 2017
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.1 years ago
Interventions
Fresh Frozen Plasmabiological
Fresh Frozen Plasma \[young (\<30 years of age) healthy male donors\] Solution for intravenous infusion